On May 31, 2022, Cumberland Pharmaceuticals Inc. announced the retirement of Leo Pavliv, Cumberland's Executive Vice President, Chief Development & Operations Officer. Mr. Pavliv previously has served as Vice President, Operations and was named Executive Vice President in 2017 and Chief Operations Officer in 2018. In that role, Mr. Pavliv was involved in various regulatory, product development and manufacturing activities for Cumberland.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.48 USD | +2.07% | -5.73% | -17.40% |
05-10 | Tranche Update on Cumberland Pharmaceuticals Inc.'s Equity Buyback Plan announced on May 13, 2010. | CI |
05-07 | Transcript : Cumberland Pharmaceuticals Inc., Q1 2024 Earnings Call, May 07, 2024 |
1st Jan change | Capi. | |
---|---|---|
-17.40% | 20.58M | |
+15.91% | 42.02B | |
+22.40% | 21.66B | |
+18.48% | 15.09B | |
+16.12% | 14.21B | |
+45.12% | 12.37B | |
-0.05% | 6.79B | |
-9.58% | 6.59B | |
-8.87% | 5.73B | |
+14.18% | 5.56B |
- Stock Market
- Equities
- CPIX Stock
- News Cumberland Pharmaceuticals Inc.
- Cumberland Pharmaceuticals Inc. Announces Executive Changes